Nektar Therapeutics to Participate in Two Investor Conferences in November
SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be participating in two upcoming investor conferences. UBS Global Biopharma Conference Format: Fireside Chat and 1x1 meetings Fireside Chat Date: Tuesday, November...